You have access
Broad-spectrum Preclinical Antitumor Activity of Eribulin (HalavenĀ®): Combination with Anticancer Agents of Differing Mechanisms
MAKOTO ASANO, JUNJI MATSUI, MURRAY J. TOWLE, JIAYI WU, SHARON MCGONIGLE, MARC HILLAIRET DE BOISFERON, TOSHIMITSU UENAKA, KENICHI NOMOTO and BRUCE A. LITTLEFIELD
Anticancer Research June 2018, 38 (6) 3375-3385; DOI: https://doi.org/10.21873/anticanres.12604